antiangiogenic drug combination TL-118

{
  "id": "MLC-T-ONC-010124",
  "term": "antiangiogenic drug combination TL-118",
  "field": "Oncology and biomedicine",
  "definition": "A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal anti-inflammatory agent, an alkylating agent, a histamine H2 antagonist and a sulfonamide with potential anti-angiogenic and antineoplastic activities. Antiangiogenic drug combination TL-118 is administrated as a specific dosing regimen and may result in a synergistic effect and reduce angiogenesis and inhibit tumor cell proliferation.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/antiangiogenic-drug-combination-tl-118/"
}